Lewis S Blevins
Overview
Explore the profile of Lewis S Blevins including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
199
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yuen K, Blevins L, Clemmons D, Faurby M, Hoffman A, Kelepouris N, et al.
Clinicoecon Outcomes Res
. 2024 Mar;
16:133-147.
PMID: 38476578
Purpose: Adult growth hormone deficiency (AGHD) is often underdiagnosed and undertreated, leading to costly comorbidities. Previously, we developed an algorithm to identify individuals in a commercially insured US population with...
2.
Osorio R, Haddad A, Hart D, Goldrich N, Badani A, Kabir A, et al.
J Neurosurg
. 2023 Oct;
140(3):712-723.
PMID: 37877974
Objective: Socioeconomic status (SES) is known to affect presentations and outcomes in pituitary neuroendocrine tumor resections, but there is a paucity of literature examining its impact specifically on patients with...
3.
Osorio R, Pereira M, Oh T, Joshi R, Haddad A, Pereira K, et al.
J Neurosurg
. 2022 Oct;
138(6):1669-1679.
PMID: 36242577
Objective: Prolactinoma is the most common pituitary adenoma and can be managed medically or surgically. The authors assessed the correlation between tumor volume and prolactin level and its effect on...
4.
Yuen K, Birkegard A, Blevins L, Clemmons D, Hoffman A, Kelepouris N, et al.
Int J Endocrinol
. 2022 Jun;
2022:7853786.
PMID: 35761982
Objective: Adult growth hormone deficiency (AGHD) is an underdiagnosed disease associated with increased morbidity and mortality. Identifying people who may benefit from growth hormone (GH) therapy can be challenging, as...
5.
Joshi R, Pereira M, Osorio R, Oh T, Haddad A, Pereira K, et al.
J Neurosurg
. 2022 Jan;
137(3):647-657.
PMID: 35090129
Objective: Diabetes insipidus (DI) following transsphenoidal surgery can adversely impact quality of life and be difficult to manage. This study sought to characterize pre- and perioperative risk factors that may...
6.
Osorio R, Pereira M, Joshi R, Donohue K, Sneed P, Braunstein S, et al.
J Neurosurg
. 2021 Oct;
136(5):1325-1336.
PMID: 34598141
Objective: Clinical presentations and outcomes of nonfunctional pituitary adenoma (NFPA) resections can vary widely, and very little prior research has analyzed this variance through a socioeconomic lens. This study sought...
7.
Aresta C, Soranna D, Giovanelli L, Favero V, Parazzoli C, Gennari L, et al.
Endocr Pract
. 2021 Jul;
27(12):1216-1224.
PMID: 34325041
Objective: To investigate whether the available literature helps to identify the characteristics of patients with type 2 diabetes (T2D) more frequently associated with hidden hypercortisolism (HidHyCo). Methods: A meta-analysis was...
8.
Young J, Oh T, Arora T, Blevins L, Aghi M, El-Sayed I, et al.
Neurosurgery
. 2021 Mar;
88(6):E571-E572.
PMID: 33693893
No abstract available.
9.
Pereira M, Oh T, Joshi R, Haddad A, Pereira K, Osorio R, et al.
Neurosurg Focus
. 2020 Oct;
49(4):E19.
PMID: 33002877
Objective: Life expectancy has increased over the past century, causing a shift in the demographic distribution toward older age groups. Elderly patients comprise up to 14% of all patients with...
10.
Haddad A, Young J, Oh T, Pereira M, Joshi R, Pereira K, et al.
Neurosurg Focus
. 2020 Jun;
48(6):E13.
PMID: 32480370
Objective: Nonfunctioning pituitary adenomas present without biochemical or clinical signs of hormone excess and are the second most common type of pituitary adenomas. The 2017 WHO classification scheme of pituitary...